Fibrin sealant (Omrix)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameFibrin sealant (Omrix)
Drug Alias NameAdhexil
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionThrombin replacementsFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsTissue AdhesionsEndometriosisOvarian Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoRussian Federation +[6] 
CombinationsYes
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOmrix Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOmrix Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsTissue AdhesionsEndometriosisOvarian Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A